openPR Logo
Press release

Peptide-drug Conjugates (PDCs) Market Size Frontier: Pioneering 13.7% CAGR Growth by 2031

06-19-2024 08:20 PM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

Peptide-drug Conjugates (PDCs) Market Size Frontier:

InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Peptide-drug Conjugates (PDCs) Market By Product (Lutetium Lu 177 dotatate, Melflufen, ANG1005, BT1718, CBX-12, and Other Pipeline Products) By Indication (Relapsed/Refractory Multiple Myeloma, Neuroendocrine Tumors (NETs), Gastric Cancers, Acromegaly, Ophthalmology, and Other Cancer Indications. )- Technology Trends, Industry Competition Analysis, Revenue and Forecast Till 2031"

According to the latest research by InsightAce Analytic, the global peptide-drug conjugates (PDCs) market is expected to record a promising CAGR of 13.7% during the period of 2023-2031. By region, North America dominates the global peptide-drug conjugates (PDCs) market with the largest share.

Request for Sample Pages: https://www.insightaceanalytic.com/report/global-peptidedrug-conjugates-pdcs-market/1351

The peptide drug conjugates are therapeutic pharmaceuticals that target tumour cells to release cytotoxin. The escalating investments by critical participants in developing promising therapies are expected to drive market growth over the forecast period. During the forecast period, it is anticipated that the emergence of Peptide-Drug Conjugates (PDCs) therapy for patients with various forms of cancer will create many clinical opportunities. PDC employs a peptide chain of approximately ten amino acids to target tumour cells, and its molecular weight is less than that of ADC, which can be rapidly enriched at tumour locations. Concurrently, drug molecules in the blood can be quickly cleared with a short half-life, thereby aiding in reducing toxic side effects induced by off-targeting.

Peptide-drug conjugates (PDCs) are an innovative targeted therapy with enhanced tumour penetration and selectivity. Peptide-drug conjugates (PDCs) are a fruitful area of research, as evidenced by the two commercially available PDCs. In addition, PDCs with the correct design and focus are anticipated to impact the therapeutic market by delivering safer medications. The increasing number of pharmaceutical drug innovations is expected to fuel the growth of the peptide-drug conjugates (PDCs) market. Due to the robust clinical pipeline of pharmaceuticals, peptide drug conjugates for treating cancer will be rapidly approved shortly. Despite these, peptide drug conjugates have many limitations that inhibit the market expansion of PDCs. The market for peptide-drug conjugates (PDCs) is primarily driven by the growing demand for therapeutic drugs, the high prevalence of cancer, the rising number of clinical trials, and the rising investments by key players to develop promising therapies. In addition, advanced medical technologies, population growth, and an increasing number of health-conscious individuals contribute to the expansion of the market.

However, the high cost of treatments, the complexity of procedures, and the absence of stringent government regulations limit market expansion. In addition, this market has been negatively affected by the COVID-19 pandemic because of the quarantine situation. In addition, the pipeline product approval procedure may impede the demand and production of the product, as numerous clinical trials are currently being conducted. In contrast, the FDA has approved very few peptide drug conjugate pipeline products over the past five years, which will impact the market during the forecast period.

Due to the high prevalence of cancer, rapid adoption of advanced technologies, rising awareness about therapeutic drugs, and rising government investments and funding in R&D for therapeutic medications, North America is expected to hold the largest share of this market over the forecast period, followed by Europe. In addition, the Asia-Pacific region is anticipated to experience substantial market expansion in the coming years due to the development of modern technologies and the rising incidence of cancer.

The key players involved in peptide-drug conjugates (PDCs) industry are Novartis AG, AstraZeneca, Bicycle Therapeutics, Cybrexa Therapeutics, Esperance Pharmaceuticals, Oncopeptides AB, Pepgen Corporation, Soricimed Biopharma, Theratechnologies, Pfizer Inc, Validus Pharmaceuticals LLC, Antisense Therapeutics, Midatech Pharma PLC, Ipsen Pharma, Chiasma, Inc., Peptron, Inc., CRINETICS PHARMACEUTICALS, Dauntless Pharmaceuticals, Camurus AB, Teva Pharmaceuticals Inc., Pharmaspur, Aspire Pharmaceuticals, Ionis Pharmaceuticals Inc, Midatech Pharma Plc, and Other Prominent Players. This field's leading players use strategies like novel therapy innovations, partnerships, collaborations, mergers, and agreements.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1351

Key developments in the market
• In Dec 2021, A strategic partnership agreement was signed between Coherent Biopharma and WuXi STA. In order to speed up the development of its current and future drug candidates (small molecules, peptides, oligonucleotides, complex chemical conjugates, etc.), from API to drug product, the company will offer Coherent Biopharma integrated CMC services.
• In Oct 2021, Oncopeptides AB announced the withdrawal of Pepaxto® (INN melphalan flufenamide) from the US market. Oncopeptides will collaborate with the FDA to keep the drug available for patients who are currently receiving Pepaxto treatment.
• In July 2020, AstraZeneca and Daiichi Sankyo formed a new $6 billion global ADC alliance to co-develop and commercialise DS-1062, a TROP2 directed DXd antibody-drug conjugate in Phase I for non-small cell lung cancer and breast cancer. The businesses will share development and commercialization costs as well as profits from DS-1062 worldwide, except for Japan.
• In June 2019, Novartis AG and PeptiDream Inc. signed a new Peptide Drug Conjugate "PDC" collaboration agreement to initiate macrocyclic peptide discovery, which will be used to address therapeutic and diagnostic applications.

Curious about Details @ https://www.insightaceanalytic.com/report/global-peptidedrug-conjugates-pdcs-market/1351

Market Segments
Global peptide-drug Conjugates (PDCs) Market, by Product, 2023-2031 (Value US$ Mn)
• Lutetium Lu 177 dotatate
• Melflufen
• ANG1005
• BT1718
• CBX-12
• Other Pipeline Products

Global peptide-drug Conjugates (PDCs) Market, by Indication, 2023-2031 (Value US$ Mn)
• Relapsed/Refractory Multiple Myeloma
• Neuroendocrine Tumors (NETs)
• Gastric Cancers
• Acromegaly
• Ophthalmology
• Other Cancer Indication

Global peptide-drug Conjugates (PDCs) Market, by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Peptide-drug Conjugates (PDCs) Market, by Country, 2023-2031 (Value US$ Mn)
• U.S.
• Canada

Europe Peptide-drug Conjugates (PDCs) Market, by Country, 2023-2031 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Peptide-drug Conjugates (PDCs) Market, by Country, 2023-2031 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Peptide-drug Conjugates (PDCs) Market, by Country, 2023-2031 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Peptide-drug Conjugates (PDCs) Market, by Country, 2023-2031 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/1351

info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide-drug Conjugates (PDCs) Market Size Frontier: Pioneering 13.7% CAGR Growth by 2031 here

News-ID: 3545407 • Views:

More Releases from InsightAce Analytic Pvt. Ltd.

Organic Feminine Care Market to Benefit from Increasing Government Initiatives and Consumer Awareness on Eco-Friendly and Sustainable Products
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma AG, LFB Biotechnologies, Grifols SA, CSL Behring, China Biologics Products Inc.
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031" The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period. Get Free Access
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Company, International Business Machines Corporation, Intel Corporation, NVIDIA Corporation.
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at
Plasma Fractionation Market Robust Expansion is expected to 2031
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),

All 5 Releases


More Releases for PDC

PDC Drill Bits Market Forecast 2025-2034 | Growth & Trends
The new report by Expert Market Research (EMR), titled 'Global PDC Drill Bits Market Report and Forecast 2025-2034', offers a comprehensive analysis of the global PDC drill bits market. The report evaluates the market based on segments such as type, cutter size, number of blades, application, and major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. It also studies the latest market trends
PDC Drill Bits Market May Set New Growth Story
Global PDC Drill Bits Market Report from DiMarket highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved
PDC Drill Bits Market Projections and Strategic Insights 2024-2030
𝐏𝐃𝐂 𝐃𝐫𝐢𝐥𝐥 𝐁𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 : Synthetic diamond cutters are used in the production of polycrystalline diamond compact (PDC) drill bits. The drilling business was revolutionised by the widespread use of PDC drill bits due to their high penetration rate and wide range of applications. PDC bit utilisation necessitates the use of special PDC cutter technology in order to maximise drilling performance across
PDC Market Sluggish Growth Rate Foreseen by 2023-2029
PDC Market Value growing at a CAGR of 6.75% during 2023-2029. Our report on the Polycrystalline Diamond Compact (PDC) market is an invaluable asset for professionals looking to make informed decisions about the future of the industry. Important changes in the business allow key players to attain larger profits. This PDCMarket study report is the best way to make changes with the help of entire market condition and metrics provided here.
Global PDC Drill Bits Market Research Report 2023-2029
Polycrystalline diamond compact (PDC) drill bits are primarily used in the drilling tools for the oil and gas industry. The fixed-head bits used in the PDC cutters for drilling are called PDC drill bits. PDC Drill Bits report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PDC Drill Bits market is projected to reach US$ 3758 million in 2029, increasing from US$ 2940.2
Global PDC Drill Bits Market Analysis by 2020-2025
Scope of the Report: The global PDC Drill Bits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Market segmentation PDC Drill Bits market is split by Type and by Application. For the period 2015-2025, the growth